My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$MRK {{ '2016-06-22T10:28:42+0000' | timeago}} • Announcement

Pharma company $MRK said a Phase 2 study of its investigational beta-lactamase inhibitor, relebactam, in combination with imipenem/cilastatin in patients with urinary tract infections met its primary endpoint. Two Phase 3 clinical studies of relebactam in combination with imipenem/cilastatin are currently ongoing and recruiting patients.

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

User Vishnu Beri {{ '2016-10-24T17:33:28+0000' | timeago}}

Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.

User Vishnu Beri {{ '2016-10-24T17:05:39+0000' | timeago}}

Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.

User Floyd Jenks {{ '2016-10-24T15:53:54+0000' | timeago}}

$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.

$CDNS {{ '2016-10-24T22:14:32+0000' | timeago}} • Webcast

$CDNS said the semiconductor and systems business are growing at levels that are not materially very different. The company added that about 40% of the company's business is in systems.

$ZION {{ '2016-10-24T22:13:56+0000' | timeago}} • Webcast

$ZION continues to expect net interest income to increase in the mid to high single-digit growth rate, driven mainly by loan and investment securities growth. The company expects that customer-related fees will be stable from the level reported in 3Q16, which include about $3MM of miscellaneous income that it does not consider likely to recur.

$ZION {{ '2016-10-24T22:05:13+0000' | timeago}} • Webcast

Over the next four quarters, $ZION expects oil and gas net charge-offs to trend downward somewhat from the last 12 months. The company expects that it will experience a gradual release of the oil and gas allowance for credit losses over the coming quarters.

$KN {{ '2016-10-24T22:03:16+0000' | timeago}} • Webcast

With regards to the capacitors market, $KN said that it faced weakness in industrial and defense markets. The company added that it is seeing a slight recovery in 3Q16 and 4Q16.

$ZION {{ '2016-10-24T22:02:34+0000' | timeago}} • Webcast

$ZION has increased the quarterly dividend rate by 33% to $0.08 per share per quarter. The company began executing on its common equity buyback plan, which calls for $180MM between July 2016 and June 2017. $ZION expects to maintain a relatively strong capital ratio, but believes the company is overcapitalized relative to its risk profile.